Dawn Carter Bir - Mar 13, 2023 Form 4 Insider Report for REATA PHARMACEUTICALS INC (RETA)

Role: Chief Commercial Officer
Signature: /s/ Tracy Herson, attorney-in-fact
Stock symbol: RETA
Transactions as of: Mar 13, 2023
Transactions value $: -$808,436
Form type: 4
Date filed: 3/15/2023, 04:44 PM
Previous filing: Mar 8, 2023
Next filing: May 17, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RETA	Class A common stock	Sale	-$808K	-9.32K	-22.44%	$86.77	32.2K	Mar 13, 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $86.74 to $87.16. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $86.74 to $87.16. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.